DexCom, Inc. is a medical device company. Co. enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. Co. is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Co. works to simplify and improve diabetes management around the world. Co. is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM).
When researching a stock like DexCom, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from DXCM Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for DXCM stock — the real life supply and demand for the stock over time — and examines that data in different ways. |
74.47
Free DXCM Email Alerts:
Video: Technical Analysis